Pulnovo Medical Appoints Ms. Jessie Lian Jia as New CEO
Pulnovo Medical Limited, a globally recognized OTM innovative platform, recently announced the appointment of Ms. Jessie Lian Jia as Chief… Read More »
Beijing 2022 Paralympics Winter Games: Equality and Respect makes Accessibility
A news report from China.org.cn on China’s parasports development: At the National Biathlon Center in Zhangjiakou, a special lane of… Read More »
Senmiao Technology Announces Ride-Hailing Platform Operating Metrics for February 2022
Senmiao Technology Limited (“Senmiao” or the “Company”) (Nasdaq: AIHS), a financing and servicing company focused on the online ride-hailing industry… Read More »
Gracell Biotechnologies Announces Details of Poster Presentation at AACR Annual Meeting 2022
Gracell to present first-in-human data on GC502, an allogeneic CD19/CD7 dual-directed chimeric antigen receptor (CAR) T cell therapy Gracell Biotechnologies… Read More »
ProfoundBio to Highlight Programs and Technology at AACR 2022 Annual Meeting; Welcomes Zhu Chen, PhD, as Chief Scientific Officer
ProfoundBio announced that preclinical data from its pipeline of novel, proprietary antibody-drug conjugates (ADCs) and technology will be presented at… Read More »
BEST Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2021 Financial Results
BEST Inc. (NYSE: BEST) (“BEST” or the “Company”), a leading integrated smart supply chain solutions and logistics services provider in China,… Read More »
Ascentage Pharma to Present Latest Results from Six Preclinical Studies at AACR Annual Meeting 2022
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related… Read More »
HISENSE SELECTS INEOS STYROLUTION’S ZYLAR 261 FOR ITS NEW RANGE OF WASHING MACHINES
Zylar® 261 selected for high clarity, high gloss surface quality and excellent ESCR performance (Environmental Stress Crack Resistance) against alcohol basis… Read More »
Alphamab Oncology to Present Clinical Data of KN026 Combined with KN046 in HER2-positive Solid Tumors at AACR 2022
Alphamab Oncology (stock code: 9966.HK) announced that data from phase II clinical study (KN026-203) of KN026 (HER2 bispecific antibody) combined… Read More »
Adagene Announces Four Poster Presentations on Robust Preclinical Pipeline of Antibody-Based Therapeutics at Upcoming American Association for Cancer Research (AACR) Annual Meeting
New IND-enabling programs reinforce commitment to build a deep, broad and differentiated pipeline that transforms cancer immunotherapy leveraging company’s AI-powered… Read More »